HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
HFE2 | Hemochromatosis type 2 (juvenile) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IDO2 | Indoleamine 2,3-dioxygenase 2 | | | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
MLIP | Muscular LMNA-interacting protein | | | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PPP1R1C | Protein phosphatase 1, regulatory (inhibitor) subunit 1C | | | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
RP11-595B24.2 | Uncharacterized protein | | | | | | Group enriched |
RP11-817J15.3 | Uncharacterized protein | | | | | | Group enriched |
RP5-966M1.6 | Musculoskeletal embryonic nuclear protein 1 | | | | | | Group enriched |
RTN4RL2 | Reticulon 4 receptor-like 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
SHD | Src homology 2 domain containing transforming protein D | | | | | | Group enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SMLR1 | Small leucine-rich protein 1 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes
| | | | | Group enriched |
TBX15 | T-box 15 | Disease related genes Transcription factors
| | | | | Group enriched |
TCTEX1D1 | Tctex1 domain containing 1 | | | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
UNC93A | Unc-93 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |
VNN1 | Vanin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
XDH | Xanthine dehydrogenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |